QR-Code

SURINPARK: Safinamide for Urinary Symptoms in Parkinson’s Disease

Background: Urinary symptoms are common, disabling and generally unresponsive to treatment in Parkinson´s disease (PD). Safinamide is approved as an add-on therapy to levodopa to improve fluctuations. Methods: Retrospective analysis of electronic records of nondemented PD patients seen consecutively...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Ana Gómez-López, Arantxa Sánchez-Sánchez, Elena Natera-Villalba, Victoria Ros-Castelló, Álvaro Beltrán-Corbellini, Samira Fanjul-Arbós, Isabel Pareés Moreno, José Luis López-Sendon Moreno, Juan Carlos Martínez Castrillo, Araceli Alonso-Canovas
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI AG 2021-01-01
Schriftenreihe:Brain Sciences
Schlagworte:
safinamide
urinary symptoms
Parkinson disease
nonmotor fluctuations
Online-Zugang:https://www.mdpi.com/2076-3425/11/1/57
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge